The Western Cape Pregnancy Exposure Registry (PER) provides ongoing surveillance of drug exposures in pregnancy and associations with pregnancyoutcomes.
Data from a hospital-based surveillance program at four hospitals in Kampala, Uganda were used to estimate the baseline prevalence of NTDs and assess potential associations with HIV status and ART use.
We explored trends and reasons for VPA use among pregnant women and WOCBA in the public sector in Western Cape Province from 1 January 2015 to 31 December 2017.
The objective of the study was to evaluate the effect of race and ethnicity on differences in maternal and perinatal outcomes among U.S.-born and foreign-born women, as well as racial and ethnic disparities in outcomes within these groups.
As infant mortality improves due to better infection control and peripartum care, congenital anomalies are becoming a key driver of pediatric survival and health.
Better outcomes are a priority for all those who care about birth defects and rare diseases. We propose three enhancements to improve the value of surveillance.
Preventing neural tube defects (NTDs) easily qualifies as a high-value opportunity to improve childhood survival and health.
We welcome contributions from members. Please submit an article for review by our editorial team.Upload now